𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer

✍ Scribed by Claudine Isaacs; Pia Herbolsheimer; Minetta C. Liu; Mary Wilkinson; Yvonne Ottaviano; Gina G. Chung; Robert Warren; Jennifer Eng-Wong; Philip Cohen; Karen L. Smith; Karen Creswell; Antonella Novielli; Rebecca Slack

Publisher
Springer US
Year
2010
Tongue
English
Weight
220 KB
Volume
125
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High circulating HER2 extracellular doma
High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: A confirmatory prospective study
✍ Ramon Colomer; Antonio Llombart-Cussac; Belen Lloveras; Manuel Ramos; Jose I. Ma πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

## Abstract ## BACKGROUND. In this specifically designed, prospective study, the authors addressed the predictive value of circulating levels of the extracellular domain (ECD) of HER2 in patients with metastatic breast cancer who were treated with letrozole. ## METHODS. Two hundred twenty‐six pa